The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM) systems.
These systems are designed for health improvement and type 2 diabetes management and are based on Abbott’s FreeStyle Libre sensing technology.
The Lingo system is aimed at consumers aged 18 and older who seek to enhance their health and wellness.
It tracks glucose levels, offering personalised insights and coaching to promote healthy habits and metabolic improvement.
